These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8184739)

  • 21. Disomy and disease resolved?
    Hastie N
    Nature; 1997 Oct; 389(6653):785, 787. PubMed ID: 9349803
    [No Abstract]   [Full Text] [Related]  

  • 22. Re: Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor.
    Morison IM; Becroft DM; Reeve AE
    J Natl Cancer Inst; 2002 Dec; 94(23):1809; author reply 1809-10. PubMed ID: 12464656
    [No Abstract]   [Full Text] [Related]  

  • 23. Role of genomic imprinting in Wilms' tumour and overgrowth disorders.
    Reeve AE
    Med Pediatr Oncol; 1996 Nov; 27(5):470-5. PubMed ID: 8827076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Signs of an imprinted domain.
    Nat Genet; 1992 Sep; 2(1):1-2. PubMed ID: 1303242
    [No Abstract]   [Full Text] [Related]  

  • 25. Multiple genetic abnormalities of 11p15 in Wilms' tumor.
    Feinberg AP
    Med Pediatr Oncol; 1996 Nov; 27(5):484-9. PubMed ID: 8827078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An overview of the clinical and molecular genetics of Wilms' tumor.
    Grundy P; Coppes M
    Med Pediatr Oncol; 1996 Nov; 27(5):394-7. PubMed ID: 8827064
    [No Abstract]   [Full Text] [Related]  

  • 27. Biology of Wilms' tumour.
    Pritchard-Jones K; Hawkins MM
    Lancet; 1997 Mar; 349(9053):663-4. PubMed ID: 9078193
    [No Abstract]   [Full Text] [Related]  

  • 28. Loss of imprinting of the IGF2 gene in a Wilms' tumor in an adult.
    Oda H; Shimizu S; Minami K; Kaneko K; Ishikawa T
    J Natl Cancer Inst; 1997 Dec; 89(23):1813-4. PubMed ID: 9392625
    [No Abstract]   [Full Text] [Related]  

  • 29. Expression of insulin-like growth factor-II transcripts in Wilms' tumour.
    Reeve AE; Eccles MR; Wilkins RJ; Bell GI; Millow LJ
    Nature; 1985 Sep 19-25; 317(6034):258-60. PubMed ID: 2995817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. t(11;11)(p13;p15) and high concentration of insulin-like growth factor II in a Wilms' tumor.
    Hayashi Y; Hanada R; Yamamoto K; Muchi H
    Cancer Genet Cytogenet; 1988 Jul; 33(1):145-7. PubMed ID: 2838157
    [No Abstract]   [Full Text] [Related]  

  • 31. [Increased expression of IGF-2 in tumor tissue of nephroblastoma].
    Briner J; Hassam S; Schönle EJ; Rohrer U
    Verh Dtsch Ges Pathol; 1989; 73():436-9. PubMed ID: 2482634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel de novo point mutation of the OCT-binding site in the IGF2/H19-imprinting control region in a Beckwith-Wiedemann syndrome patient.
    Higashimoto K; Jozaki K; Kosho T; Matsubara K; Fuke T; Yamada D; Yatsuki H; Maeda T; Ohtsuka Y; Nishioka K; Joh K; Koseki H; Ogata T; Soejima H
    Clin Genet; 2014 Dec; 86(6):539-44. PubMed ID: 24299031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular analysis of patients with Wiedemann-Beckwith syndrome. II. Paternally derived disomies of chromosome 11.
    Nyström A; Cheetham JE; Engström W; Schofield PN
    Eur J Pediatr; 1992 Jul; 151(7):511-4. PubMed ID: 1356785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delayed onset of Igf2-induced mammary tumors in Igf2r transgenic mice.
    Wise TL; Pravtcheva DD
    Cancer Res; 2006 Feb; 66(3):1327-36. PubMed ID: 16452186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acromegalic pregnancy associated with a Beckwith-Wiedemann fetus.
    Luton D; Lepercq J; Sibony O; Barbet P; Le Bouc Y; Chavinié J; Lewin F
    Fetal Diagn Ther; 1996; 11(2):154-8. PubMed ID: 8838774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular biology of Beckwith-Wiedemann syndrome.
    Weksberg R; Squire JA
    Med Pediatr Oncol; 1996 Nov; 27(5):462-9. PubMed ID: 8827075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of imprinting in human cancer.
    Feinberg AP; Kalikin LM; Johnson LA; Thompson JS
    Cold Spring Harb Symp Quant Biol; 1994; 59():357-64. PubMed ID: 7587088
    [No Abstract]   [Full Text] [Related]  

  • 38. Revisiting Wilms tumour surveillance in Beckwith-Wiedemann syndrome with IC2 methylation loss, reply.
    Brioude F; Hennekam R; Bliek J; Coze C; Eggermann T; Ferrero GB; Kratz C; Bouc YL; Maas SM; Mackay DJG; Maher ER; Mussa A; Netchine I
    Eur J Hum Genet; 2018 Apr; 26(4):471-472. PubMed ID: 29449718
    [No Abstract]   [Full Text] [Related]  

  • 39. Beckwith-Wiedemann syndrome.
    Norman AM; Read AP; Donnai D
    J Med Genet; 1992 Sep; 29(9):679. PubMed ID: 1404305
    [No Abstract]   [Full Text] [Related]  

  • 40. Molecular analysis of patients with Wiedemann-Beckwith syndrome. I. Gene dosage on the short arm of chromosome 11.
    Nyström A; Engström W; Cheetham J; Schofield PN
    Eur J Pediatr; 1992 Jul; 151(7):504-10. PubMed ID: 1356784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.